InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Monaghan Matthew E., Chairman & CEO. Insider active across 2 companies, notably Syneos Health, Inc.. In total, 10 filings have been recorded. Breakdown: 1 buy · 2 sells. Total volume traded: €71k. Activity tracked since 12 May 2021. The latest transaction was disclosed on 28 September 2023 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Monaghan Matthew E.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
19,777 shares@ US$43.0095.3% of flowClass A Common StockSEC:0001209191-23-050775:0
4,863 shares0Class A Common StockSEC:0001209191-23-032945:0
200 shares@ US$74.3535.2% of flowClass A Common StockSEC:0001209191-22-033588:0
2,839 shares0Class A Common StockSEC:0001209191-22-032643:0
47,445 shares@ US$1.095.0% of flowCommon SharesSEC:0001209191-22-029749:0
294,391 shares0Common SharesSEC:0001209191-22-023084:0
32,800 shares@ US$1.494.5% of flowCommon SharesSEC:0001209191-22-018482:0
Canonical exit: 9 Jun 2022 (T+90)
170 shares@ US$88.641.5% of flowClass A Common StockSEC:0001209191-21-047208:0
65,694 shares@ US$8.2082.6% of flowCommon SharesSEC:0001209191-21-033553:0
2,364 shares0Class A Common StockSEC:0001209191-21-032820:0
10 of 10 declarations
About Monaghan Matthew E.
Monaghan Matthew E. serves as Chairman, President, and CEO at Syneos Health, Inc. and INVACARE CORP. He leads the companies by defining the strategic vision and overseeing operational execution. His leadership is essential for steering the organizations towards their growth and innovation objectives.
